Stephanie L. Baringer

Stephanie L. Baringer

Auto-generated profile, based on publicly available information

Stephanie L. Baringer

Department of Neurosurgery Penn State College of Medicine Hershey Pennsylvania USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2023 in Journal of Biological Chemistry
Verified
Journal Article
Open access
KPKondaiah Palsa
Kondaiah Palsa
SBStephanie L. Baringer
Stephanie L. Baringer
GSGanesh Shenoy
Ganesh Shenoy
VSVladimir S. Spiegelman
Vladimir S. Spiegelman
ISIan A. Simpson
Ian A. Simpson
JCJames R. Connor
James R. Connor
Iron is essential for normal brain development and function. Hence, understanding the mechanisms of iron efflux at the blood-brain barrier and their regulation are critical for the establishment of brain iron homeostasis. Here, we have investigated the role of exosomes in mediating the transfer of H-ferritin (FTH1)- or transferrin (Tf)-bound iron across the blood-brain barrier endothelial cells (BBBECs). Our study used ECs derived from human-induced pluripotent stem cells that are grown in bicameral chambers. When cells were exposed to 55Fe-Tf or 55Fe-FTH1, the 55Fe activity in the exosome fraction in the basal chamber was significantly higher compared to the supernatant fraction. Furthermore, we determined that the release of endogenous Tf, FTH1, and exosome number is regulated by the iron concentration of the endothelial cells. Moreover, the release of exogenously added Tf or FTH1 to the basal side via exosomes was significantly higher when ECs were iron loaded compared to when they were iron deficient. The release of exosomes containing iron bound to Tf or FTH1 was independent of hepcidin regulation, indicating this mechanism by-passes a major iron regulatory pathway. A potent inhibitor of exosome formation, GW4869, reduced exosomes released from the ECs and also decreased the Tf- and FTH1-bound iron within the exosomes. Collectively, these results indicate that iron transport across the blood-brain barrier is mediated via the exosome pathway and is modified by the iron status of the ECs, providing evidence for a novel alternate mechanism of iron transport into the brain.

12 April 2023 in Journal of Neurochemistry
Verified
Journal Article
Open access
SBStephanie L. Baringer
Stephanie L. Baringer
ISIan A. Simpson
Ian A. Simpson
JCJames Connor
James Connor
Brain iron homeostasis is crucial for neurological health, with pathological fluctuations in brain iron levels associated with a variety of neurological disorders. Low levels are connected to cognitive impairment and restless legs syndrome, while high levels are connected to Alzheimer's disease, Parkinson's disease, and other neurodegenerative diseases. Given the detrimental effects unrestricted iron can have, regulated entry into the brain via transferrin and H‐ferritin is critical. Endothelial cells of the blood–brain barrier are the site of iron transport regulation. The movement of iron through endothelial cells into the brain can be divided into three distinct processes: uptake, transcytosis, and release. Each process possesses external and internal influences on the regulation at each stage. This review discusses the mechanisms of iron uptake, transcytosis, and release at the blood–brain barrier, as well as the elements that contribute to regulation. Additionally, we explore the dysregulation of brain iron in Alzheimer's disease, Parkinson's disease, and restless legs syndrome. image

10 June 2022 in Fluids and Barriers of the CNS
Verified
Journal Article
Open access
PDF file
SBStephanie L. Baringer
Stephanie L. Baringer
ENElizabeth B. Neely
Elizabeth B. Neely
KPKondaiah Palsa
Kondaiah Palsa
ISIan A. Simpson
Ian A. Simpson
JCJames Connor
James Connor
Background: The brain requires iron for a number of processes, including energy production. Inadequate or excessive amounts of iron can be detrimental and lead to a number of neurological disorders. As such, regulation of brain iron uptake is required for proper functioning. Understanding both the movement of iron into the brain and how this process is regulated is crucial to both address dysfunctions with brain iron uptake in disease and successfully use the transferrin receptor uptake system for drug delivery. Methods: Using in vivo steady state infusions of apo- and holo-transferrin into the lateral ventricle, we demonstrate the regulatory effects of brain apo- and holo-transferrin ratios on the delivery of radioactive 55Fe bound to transferrin or H-ferritin in male and female mice. In discovering sex differences in the response to apo- and holo-transferrin infusions, ovariectomies were performed on female mice to interrogate the influence of circulating estrogen on regulation of iron uptake. Results: Our model reveals that apo- and holo-transferrin significantly regulate iron uptake into the microvasculature and subsequent release into the brain parenchyma and their ability to regulate iron uptake is significantly influenced by both sex and type of iron delivery protein. Furthermore, we show that cells of the microvasculature act as reservoirs of iron and release the iron in response to cues from the interstitial fluid of the brain. Conclusions: These findings extend our previous work to demonstrate that the regulation of brain iron uptake is influenced by both the mode in which iron is delivered and sex. These findings further emphasize the role of the microvasculature in regulating brain iron uptake and the importance of cues regarding iron status in the extracellular fluid.

4 September 2023 in Journal of Neurochemistry
Verified
Journal Article
Open access
SBStephanie L. Baringer
Stephanie L. Baringer
ALAvraham S. Lukacher
Avraham S. Lukacher
KPKondaiah Palsa
Kondaiah Palsa
HKHyosung Kim
Hyosung Kim
ELEthan S. Lippmann
Ethan S. Lippmann
JCJames Connor
James Connor
Excessive brain iron accumulation is observed early in the onset of Alzheimer's disease, notably prior to widespread proteinopathy. These findings suggest that increases in brain iron levels are due to a dysregulation of the iron transport mechanism at the blood–brain barrier. Astrocytes release signals (apo‐ and holo‐transferrin) that communicate brain iron needs to endothelial cells in order to modulate iron transport. Here we use iPSC‐derived astrocytes and endothelial cells to investigate how early‐disease levels of amyloid‐β disrupt iron transport signals secreted by astrocytes to stimulate iron transport from endothelial cells. We demonstrate that conditioned media from astrocytes treated with amyloid‐β stimulates iron transport from endothelial cells and induces changes in iron transport pathway proteins. The mechanism underlying this response begins with increased iron uptake and mitochondrial activity by the astrocytes, which in turn increases levels of apo‐transferrin in the amyloid‐β conditioned astrocyte media leading to increased iron transport from endothelial cells. These novel findings offer a potential explanation for the initiation of excessive iron accumulation in early stages of Alzheimer's disease. What's more, these data provide the first example of how the mechanism of iron transport regulation by apo‐ and holo‐transferrin becomes misappropriated in disease that can lead to iron accumulation. The clinical benefit from understanding early dysregulation in brain iron transport in AD cannot be understated. If therapeutics can target this early process, they could possibly prevent the detrimental cascade that occurs with excessive iron accumulation. image

1 March 2021 in DNA Repair
Verified
Journal Article
Closed access
BBBeverly A. Baptiste
Beverly A. Baptiste
SBStephanie L. Baringer
Stephanie L. Baringer
TKTomasz Kulikowicz
Tomasz Kulikowicz
JSJoshua A. Sommers
Joshua A. Sommers
DCDeborah L. Croteau
Deborah L. Croteau
VBVilhelm A. Bohr
Vilhelm A. Bohr

30 November 2023 in The FASEB Journal
Verified
Journal Article
Open access
KPKondaiah Palsa
Kondaiah Palsa
ENElizabeth B. Neely
Elizabeth B. Neely
SBStephanie L. Baringer
Stephanie L. Baringer
THTimothy B. Helmuth
Timothy B. Helmuth
ISIan A. Simpson
Ian A. Simpson
JCJames Connor
James Connor
Adequate and timely delivery of iron is essential for brain development. The uptake of transferrin‐bound (Tf) iron into the brain peaks at the time of myelination, whereas the recently discovered H‐ferritin (FTH1) transport of iron into the brain continues to increase beyond the peak in myelination. Here, we interrogate the impact of dietary iron deficiency (ID) on the uptake of FTH1‐ and Tf‐bound iron. In the present study, we used C57BL/6J male and female mice at a developing (post‐natal day (PND) 15) and adult age (PND 85). In developing mice, ID results in increased iron delivery from both FTH1 and Tf for both males and females. The amount of iron uptake from FTH1 was higher than the Tf and this difference between the iron delivery was much greater in females. In contrast, in the adult model, ID was associated with increased brain iron uptake by both FTH1 and Tf but only in the males. There was no increased uptake from either protein in the females. Moreover, transferrin receptor expression on the microvasculature as well as whole brain iron, and H and L ferritin levels revealed the male brains became iron deficient but not the female brains. Last, under normal dietary conditions, 55 Fe uptake was higher in the developing group from both delivery proteins than in the adult group. These results indicate that there are differences in iron acquisition between the developing and adult brain for FTH1 and Tf during nutritional ID and demonstrate a level of regulation of brain iron uptake that is age and sex‐dependent.